Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1926798
                    [Title] => NASH rapidly overtaking hepatitis C as cause of liver cancer
                    [Summary] => Nonalcoholic steatohepatitis (NASH) is rapidly eclipsing hepatitis C virus (HCV) infection as the leading contributor to liver cancer in the United States.
                    [DatePublished] => 2019-06-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

Nonalcoholic steatohepatitis

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1926798
                    [Title] => NASH rapidly overtaking hepatitis C as cause of liver cancer
                    [Summary] => Nonalcoholic steatohepatitis (NASH) is rapidly eclipsing hepatitis C virus (HCV) infection as the leading contributor to liver cancer in the United States.
                    [DatePublished] => 2019-06-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

NASH rapidly overtaking hepatitis C as cause of liver cancer

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | June 16, 2019 - 12:00am

Nonalcoholic steatohepatitis (NASH) is rapidly eclipsing hepatitis C virus (HCV) infection as the leading contributor to liver cancer in the United States.

Opinion